Bare -Metal Stents and Drug -Eluting Stents in the Treatment of Patients With Vertebral Artery Ostium Stenosis

NCT02197559 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 168

Last updated 2016-10-24

No results posted yet for this study

Summary

The study hypothesizes that Drug -eluting stents are more effective in preventing restenosis than Bare-metal stents after Vertebral Artery Ostium stenting

Conditions

Interventions

PROCEDURE

DES group

all the participants in this group will be performed with drug -eluting stents

PROCEDURE

BMS group

all the participants in this group will be performed with bare-metal stents

Sponsors & Collaborators

  • Xuanwu Hospital, Beijing

    lead OTHER

Principal Investigators

  • Feng Ling, M.D. · Xuanwu Hospital, Capital University of Medical Sciences, Beijing, China

Eligibility

Min Age
35 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-06-30
Completion
2016-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02197559 on ClinicalTrials.gov